FIRST YOU SHOULD KNOW

About Medisa

Medisa is dedicated to developing generic peptide and oligonucleotide-based therapies to address medical needs. We leverage cutting-edge technology to manufacture these advanced drugs, offering targeted solutions for a wide range of diseases.

Medisa is generic drug manufacturer. Generic drugs are copies of brand-name drugs that have the same active ingredients, strength, dosage form, and route of administration as the original brand-name drug.

Advancement in Peptide Drug Technology 85%

Customer and Patient Satisfaction 92%

Growth and Innovation in Oligonucleotide Therapies 78%

Cost Optimization in Generic Drug Production 80%

check it out

Our Products

Peptide Drugs:

Peptide drugs are a class of medications composed of short chains of amino acids, the building blocks of proteins. These molecules offer a targeted approach to treating various diseases by interacting with specific receptors or enzymes. Unlike traditional small molecule drugs, peptide drugs often exhibit greater specificity and reduced side effects. Peptide drugs are gaining significant attention in the pharmaceutical industry due to their versatility and potential to address unmet medical needs. They are being investigated for a wide range of applications, including cancer treatment, diabetes management, and neurological disorders. As research and development in peptide drug technology continue to advance, we can expect to see even more innovative and effective therapies emerging in the future.

Oligonucleotide Drugs:

Oligonucleotide drugs are short, synthetic DNA or RNA molecules that can be designed to target specific genes or RNA sequences. These molecules offer a novel approach to treating diseases by interfering with gene expression or modulating protein function. Oligonucleotide drugs have emerged as a promising therapeutic modality with the potential to revolutionize medicine. They are being investigated for a wide range of diseases, including cancer, viral infections, and genetic disorders. By targeting specific genetic targets, oligonucleotide drugs offer a highly targeted approach to treatment, minimizing off-target effects and maximizing therapeutic efficacy.

Wanna say hello?

Contact Us

Phone: 021-88487738
Fax: Deprecated!

Head office and Manufacturing site Address:
Building No. 5, Azadi Innovation Factory, Shahid Lashgari Highway, Tehran
1391955413

locate us on the map
close the map